00:00 – Dr. Hsieh: Some patients are prone to UTIs caused by bacteria that don’t grow very well
00:05 – in conventional conditions.
00:20 – Melissa: Let’s move on to the topic of UTI testing, which is one of the biggest topics
00:24 – that we have questions on at Live UTI Free. First of all, do you think
00:28 – the standard urine culture can be used to rule out urinary tract infection?
00:34 – Dr. Hsieh: I think in some patients conventional urine cultures are very helpful and in fact,
00:44 – perhaps the majority of patients. As to why some patients who clearly have UTIs often have negative
00:53 – results on conventional urine cultures is less clear. A few reasons that make sense,
01:00 – one is that some patients are very sensitive to very low colony counts of bacteria in their urine.
01:09 – And then another explanation is that some patients are prone to UTIs caused by bacteria that don’t grow very well in conventional conditions.
01:20 – Melissa: Do you feel like that’s becoming more and more common
01:22 – or is it more that you have other tools now to use so you’re seeing these other organisms?
01:30 – Dr. Hsieh: That’s an excellent question. You know that that refers to the possibility of detection bias.
01:36 – Are we really seeing a shift in UTI biology amongst patients or has this always been the case?
01:44 – You know reading some papers carefully I actually think that
01:53 – there’s always been this important subset of patients who clearly have UTI symptoms and yet
02:00 – their conventional urine cultures are negative. If you look carefully at these papers they’ll say
02:06 – oh, 20% of patients had persistent symptoms despite negative cultures, and it’s glossed over unfortunately.
02:14 – Melissa: Even though that a significant number of patients.
02:16 – Dr. Hsieh: Yes, yes it is.
02:18 – Melissa: Do you think for some people with interstitial cystitis there’s a bacterial component?
02:25 – Dr. Hsieh: Yeah, very controversial and very important topic. I think on both sides there have been some
02:32 – misdiagnoses. I don’t know how many, and by both sides I mean that I do think that some patients
02:41 – told that they have UTIs have actually interstitial cystitis and vice versa. There are
02:46 – definitely patients who have interstitial cystitis who actually have recurrent or persistent UTIs.
02:56 – Alignment with this context, we see that it is a spectrum.
02:56 – Melissa: How would you go about making that distinction in a patient who is somewhere on that spectrum?
03:02 – Dr. Hsieh: It can be difficult and i definitely don’t have all the answers. In some cases
03:07 – I do feel fortunate that I think i’ve been able to sort it out with the patient’s help. So you
03:15 – know, maybe I’ll start by giving the extreme very clear examples. You know I think patients who
03:24 – have consistently positive urine cultures who respond consistently to antibiotics
03:33 – clearly have UTIs and that seems like a very easy case. But believe it or not, I’ve seen a fair number of patients
03:43 – who fit that scenario and yet because of the recurrent nature of their infections have
03:48 – somehow been told by other providers that they have IC which flabbergasts me.
03:56 – The other extreme would be patients who never have positive urine cultures,
04:04 – never respond positively to antibiotics and have waxing and waning symptoms of IC.
04:13 – The classic ones being urinary urgency frequency and pain that improve after voiding.
04:22 – Melissa: What do you think about the theory of embedded infection in the bladder and how that might relate to the failure to respond to antibiotics?
04:30 – Dr. Hsieh: Well, I do think that clearly bacteria have strategies that
04:38 – allow them to persist in the urinary tract or at least reinfect the urinary tract
04:45 – and there’s quite a bit of accumulated data at this point. Both in models of UTI
04:53 – as well as clinical data. So one of the major theories is that patients sometimes have biofilms
05:02 – of bacteria in their bladders. And the biofilm of course is basically a slime
05:10 – that the bacteria can live in to hide out from the immune system and possibly antibiotics as well.
05:16 – Now these biofilms can either be on the surface of the lining of the bladder and they can also be
05:24 – within the cells themselves. The other major theory as to how persistent
05:31 – or at least recurrent UTIs can occur is reseeding from the gut. So there’s
05:39 – actually fairly recent data indicating that many patients prone to recurrent UTIs have a bloom of
05:50 – E. coli in their gut before a UTI episode, which
05:57 – in conjunction with older data showing that many of the E. coli strains found in the gut can also
06:03 – cause UTIs is consistent with the reseeding theory.
06:07 – Melissa: Do you think it’s always reseeding in that case or could it be the bacteria communicating with each other across organs somehow?
06:17 – Dr. Hsieh: Well that’s a very interesting theory. I’ll say that pelvic organs definitely have
06:26 – crosstalk, as it’s referred to. So there may be indirect communication between bacteria across
06:34 – those organs since others have shown that your microbiome, the collection of all your bacteria
06:42 – in your gut, can certainly affect the crosstalk between the gut and the urinary tract.
06:51 – Melissa: People also often refer to their UTI symptoms, and sometimes with positive test results too,
06:56 – coming on with stress. Or like the bacteria just being opportunistic. They can see that something’s
07:01 – going on and they take their opportunity to multiply. Can you explain why that might happen?
07:10 – Dr. Hsieh: Yes, so I have had patients who’ve expressed that this has been their experience.
07:21 – It does make plausible sense that perhaps one could have
07:28 – a milder form of immunosuppression associated with stress. So for example,
07:33 – stress increases cortisol, which is a immunosuppressive steroid.
07:39 – Now it hasn’t been studied to my knowledge but that does not mean it does not occur.
07:46 – Melissa: I think it’s quite interesting the number of people who report this as a sequence of events and it would be great if we could do some research.
07:59 – Dr. Hsieh: Yeah, I will say anecdotally it also seems clear that stress in general magnifies urinary symptoms. How that works mechanistically
08:09 – I’m not certain. That being said, I do think that many stressed out patients focus more on their
08:18 – urinary symptoms in general and perhaps there’s a vicious cycle occurring in that situation.
08:24 – Melissa: I would say it’s quite difficult not to focus on bladder symptoms especially given the
08:30 – brain is wired to tell you something’s going on there, very difficult to forget.
08:34 – Dr. Hsieh: Of course.
08:36 – Melissa: You’ve spoken a lot about using urinary microbiome testing as well to provide
08:41 – more insight sometimes for patients where they test negative on culture. Do you often use
08:47 – multiple types of testing alongside culture or is it always something you do independently?
08:53 – Dr. Hsieh: When I first see a patient I will tend to send off what are called
09:01 – enhanced quantitative urine cultures, in conjunction with microbiome testing,
09:08 – which is essentially detection of bacterial DNA in the urine. The reason I do that is there are
09:18 – a fair number of patients in my experience who may have negative conventional urine cultures but
09:25 – still positive cultures when you do what are called enhanced quantitative urine cultures.
09:31 – In those patients, the enhanced quantitative urine cultures I think are are actually
09:40 – more accepted by the medical community than the microbiome testing because ultimately it’s still
09:48 – growth-based. Now there’s also another important segment of at least my patient population where
09:56 – even enhanced quantitative cultures are negative.
10:00 – In which case I tend to rely more on microbiome testing. That being said, I think microbiome testing
10:09 – for clinical use is still relatively unestablished and we we don’t know the optimal ways to
10:22 – interpret these results and which patients would most benefit from this type of testing.
10:29 – Melissa: Do you see differences in patient outcomes across those different types of tests?
10:36 – Dr. Hsieh: I do, and another interesting observation is that the tests often disagree,
10:46 – It’s not overly surprising because the technology that underlies each of these testing platforms
10:55 – is different but it adds an extra layer of challenge in terms of interpretation
11:01 – of results when you have to reconcile differing findings across tests.
11:07 – Melissa: Do you only tend to treat things that are known pathogens, or sometimes you have to go outside that because of what you find?
11:16 – Dr. Hsieh: Certainly known pathogens, especially E. coli in a symptomatic patient I will try to treat.
11:24 – But you are correct. Many times, especially on microbiome testing, more unusual organisms
11:31 – that are poorly characterized in general and may or may not be your pathogens, do appear.
11:38 – And then it becomes especially challenging. The dilemma is whether or not treatment should be directed against these organisms as well.
11:48 – Melissa: Have you had any cases where a very unusual organism has come back on a test and treatment has resulted in improvement in symptoms?
11:58 – Dr. Hsieh: You know most of the time when patients have unusual organisms on their microbiome testing
12:05 – they usually also have more conventional uropathogens, and I tried to treat those
12:13 – patients with antibiotics that would cover both the better known bacteria as well as the
12:23 – unconventional potential pathogens.
12:25 – Melissa: So it would be hard to differentiate what caused the symptom relief in that case?
12:32 – Dr. Hsieh: It can be. Antibiotics very rarely can target only a single bacteria.
12:38 – Melissa: One of the questions that comes up quite a bit around the microbiome testing that’s based on DNA sequencing is about the DNA itself.
12:46 – So on one hand we’re often told that DNA begins to break down quite quickly once an organism is no
12:52 – longer alive, but on the other we’re told that they can sequence DNA from fossils that are millions of years old. So what is the correct answer here for
13:02 – urine samples. Are the DNA alive or are they dead, or can you just not tell?
13:09 – Dr. Hsieh: That’s a very important question. The underlying assumption with microbiome testing is that
13:18 – any bacterial DNA we detect is important but presumably only live bacteria will cause urinary
13:29 – symptoms associated with the UTI. So I think current testing platforms do not distinguish
13:40 – between DNA from live versus dead bacteria which is a major limitation. Other fields in microbiology
13:49 – have shown that DNA from live versus dead bacteria do make a difference in various contexts.
13:59 – Melissa: Okay, and are you able to talk about the research that you’re doing in this area?
14:07 – Dr. Hsieh: Yes. So a number of years ago another urologist’s interest in the microbiome questioned whether
14:18 – the DNA that we’re detecting is from live or dead bacteria and thus if it’s clinically important.
14:27 – And that really stuck in my head. So we’re currently, in my laboratory, trying to develop
14:34 – methods to distinguish between DNA from live versus dead bacteria in urine samples and hope to do a clinical study very soon.
14:46 – Melissa: What’s the timeline on that do you think?
14:50 – Dr. Hsieh: We are actually poised to start testing clinical samples hopefully in the next few months.
14:58 – Melissa: That’s interesting. And the results from this research, is that kind of a few years away or sooner?
15:06 – Dr. Hsieh: Hopefully within a year we’ll have published.
15:08 – But you know the cogs of academia turn slowly. I will
15:16 – upload it first as a pre-print so that the findings are publicly available. Of course,
15:24 – findings uploaded to pre-print are not peer-reviewed and should be taken with a grain of salt.
15:32 – Melissa: We’ll be looking out for that research, definitely.
Key Take Aways
Defining Complicated Infection
Bacterial Drug Resistance Mechanism
Anatomical Drug Distribution Barriers
Dynamic Resistance Cost Factors
Synergistic Bladder Instillation Benefits
Immunological Bacteriostatic Cooperation

Stay up to date with our latest videos, interviews, insights, and musings from the Live UTI Team





Interviews, insights, and musings from the Live UTI Team, and Industry Professionals.
